We further performed IHC staining in a cohort of 355 paraffin-embedded NPC samples (Supplementary Fig. 8b and Supplementary Table 3) and found that NPC patients who developed locoregional recurrence had higher TRIM21 expression levels than those who remained tumour-free (Fig. 7e). This evidence concerns the gene TRIM21 and neoplasm.